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Available online 4 January 2011Planar cell polarity (PCP) establishes polarity within an epithelial sheet. Defects in PCP are associated with
developmental defects involving directional cell growth, including defects in kidney tubule elongation that
lead to formation of kidney cysts. Given the strong association between kidney cyst formation and
developmental biliary defects in patients and in animal models, we investigated the importance of PCP in
biliary development. Here we report that in zebraﬁsh, morpholino antisense oligonucleotide-mediated
knockdown of PCP genes including prickle-1a (pk1a) led to developmental biliary abnormalities, as well as
localization defects of the liver and other digestive organs. The defects in biliary development appear to be
mediated via downstream PCP targets such as Rho kinase, Jun kinase (JNK), and both actin and microtubule
components of the cytoskeleton. Knockdown of pk1a led to decreased expression of vhnf1, a homeodomain
gene previously shown to be involved in biliary development and in kidney cyst formation; forced expression
of vhnf1 mRNA led to rescue of the pk1a morphant phenotype. Our results demonstrate that PCP plays an
important role in vertebrate biliary development, interacting with other factors known to be involved in
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Planar cell polarity (PCP) is an essential property of multicellular
tissues, mediating polarity within the epithelial plane perpendicular
to apical–basal polarity. PCP involves noncanonical Wnt signaling, in
which transmembrane receptors Frizzled, Strabismus (Vangl in
vertebrates), or Flamingo (Celsr) recruit the adaptor protein Dishev-
elled (Dsh), which in turn activates the Jun kinase-Rac-Rho pathway
to alter cytoskeletal dynamics and gene expression. Other conserved
PCP components include the soluble factors Prickle (Pk) and Diego
(Ankrd6 in vertebrates). The Flamingo/Strabismus/Prickle complex is
generally located on the proximal side of an epithelial cell, while the
Flamingo/Frizzled/Dishevelled/Diego complex is on the distal side,
although Prickle acts on this complex as well (Zallen, 2007).
Defects in PCP signaling lead to several migration-related
developmental defects, including defects in gastrulation (Takeuchi
et al., 2003; Wallingford et al., 2000), islet cell migration into the
pancreas, neuroepithelial migration into the eye, and the develop-
ment of stereocilia in the inner ear (Karner et al., 2006). Defective
signaling via PCP family members leads to the generation of renal
cysts due to a role in directional tubule elongation during kidney
development (Fischer et al., 2006; Saburi et al., 2008). We wereintrigued by this observation, as there is a strong association between
kidney cysts and abnormalities in intrahepatic biliary development.
Ductal plate malformations, which are thought to represent abnor-
malities in intrahepatic biliary development (Desmet, 1998), are seen
in autosomal recessive polycystic kidney disease, as well as in other
genetic conditions such as Bardet–Biedl syndrome, Jeune asphyxiat-
ing thoracic dysplasia, and Meckel–Gruber syndrome, which also
demonstrate cystic kidneys (Maclean and Dunwoodie, 2004).
Zebraﬁsh have been well established as a model to study
hepatobiliary development. While intrahepatic biliary development
in zebraﬁsh does not proceed via a ductal plate intermediate stage,
there is otherwise strong conservation in terms of overall develop-
mental process and in speciﬁc genetic pathways important in both
zebraﬁsh and mammalian biliary development. Apical–basal polarity
of the hepatocyte is established prior to formation of the initial
intrahepatic ducts (Sakaguchi et al., 2008), which lengthen and then
remodel to become an interconnected lattice that drains the liver by 5
dpf (days post fertilization) (Lorent et al., 2010; Lorent et al., 2004;
Matthews et al., 2004). Mediators of intrahepatic bile duct formation
in mammals, such as Onecut family members (Clotman et al., 2005;
Clotman et al., 2002), the homeodomain transcription factor Hnf1b
(vhnf1 in zebraﬁsh) (Cofﬁnier et al., 2002), and Jagged and Notch
(Kodama et al., 2004; Lozier et al., 2008), also function in zebraﬁsh
biliary development (Lorent et al., 2010; Lorent et al., 2004; Matthews
et al., 2008; Matthews et al., 2004). Thus, we tested our hypothesis
that inhibition of PCP negatively affects biliary development using
zebraﬁsh.
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zebraﬁsh, and veriﬁed their expression in the developing liver during
biliary growth and remodeling. Knockdown of pk1a and other PCP
genes using morpholino antisense oligonucleotides demonstrated
impaired bile duct formation, and also led to defects in left-right
localization of digestive organs. Inhibitors of downstream targets of
PCP such as Rho kinase and JNK also elicited biliary defects, supporting
a role for PCP in biliary development. Furthermore, vhnf1 expression
was decreased in pk1a morphants, and forced expression of vhnf1
rescued the biliary defects seen in pk1a morphants. These studies




Zebraﬁsh were raised and housed in accordance with standard
procedures, under protocols approved by the Institutional Animal
Care and Use Committees (IACUCs) of The Children's Hospital of
Philadelphia and the University of Pennsylvania. All wild-type ﬁsh
used for these studies were top long ﬁn (TLF).
In situ hybridization
Antisense riboprobes for pk1a, dsh2, vangl2, dsh3, wnt11, wnt11r,
ankrd6, prickle2, celsr1, celsr2, celsr3, ceruloplasmin (cp), fabp2, trypsin
(try) and insulin (ins) were synthesized directly from PCR products by
using a T3 sequence that had been synthesized at the 5' end of the
reverse primer (see Supplementary Table 1 for primer sequences).
The PCR product was puriﬁed and then used as template for riboprobe
synthesis as per standard protocols. The remainder of the in situ
protocol was essentially as described previously (Wallace and Pack,
2003), using larvae raised in phenylthiourea (PTU) to inhibit the
development of pigment, as per standard protocols.
Morpholino oligonucleotides and drug treatments
Morpholino oligonucleotides (MOs) were designed based on
sequences available from the zebraﬁsh genome assembly. All MOs
were obtained from GeneTools (http://www.gene-tools.com; Philo-
math, OR), including standard and random control MOs. Morpholinos
were designed to target the 5' translational start site and the splice
acceptor site for exon 7 of the pk1a gene, for the 5' end and splice
donor site of exon 1 for vangl2, and for the 5' translational start site
and splice acceptor site for exon 2 for ankrd6 (Table S1). The hnf6MOs
have been detailed previously (Matthews et al., 2004). For all
morpholinos, 1.5 ng was injected at the one-cell stage or at 48 hpf.
Injections at 48 hpf were into the yolk, similar to previous studies
(Matthews et al., 2009; Stenkamp and Frey, 2003). Injection with
either the ATG or splice blocking MOs produced identical phenotypes,
and knockdownwas conﬁrmed using 1.5 ngMO, by PCR or bywestern
blot using antibodies directed against Prickle (Santa Cruz) (Fig. S1).
For the epistasis experiments with pk1a MO and colchicine or
cytochalasin D, 0.38 ng MO was injected. For the mRNA rescue
experiments, pk1a or vhnf1mRNA was synthesized from a full-length
pk1a PCR product using mMessage mMachine (Ambion), after the
cDNA had been cloned into pCS2(+), similar to previous studies
(Matthews et al., 2004). mRNA was injected at the one-cell stage,
using 14 pg mRNA for either, similar to previous.
For the chemical and drug injections, 4 ng of the actin inhibitor
cytochalasin D (Sigma) was injected into the yolk of 2 dpf larvae, and
for the microtubule inhibitor colchicine (Sigma), 20 pg was injected
into the yolk. For the RhoA target inhibitor fasudil (Sigma), 10 ng was
injected at the 1 cell stage. 6 ng of the JNK inhibitor dicoumeral
(Sigma) was injected at 2 dpf. For the Rho kinase inhibitor H-1152(RKI, EMD Chemicals), 1 ng was injected at 2 dpf. The above doses
were determined based on initial titration experiments, and the
volume injected was approximately 2 nl, consistent with standard
volumes used in MO injection experiments. For the epistasis
experiments, 1 ng cytochalasin D or 5 pg colchicine was used with
0.38 ng MO as noted above.
PED-6 treatment
Control andmorpholino-injected larvae at 5 dpf were soaked 2 h in
0.1 μg/ml PED-6, similar to previous studies (Matthews et al., 2004).
Larvae were sorted and counted based on gallbladder intensity and
location, as indicated in Results. For purposes of quantiﬁcation,
gallbladders were scored as “normal,” “faint,” “absent,” or “left.” The
distinction between “normal” and “faint” was necessarily subjective,
based on the intensity of ﬂuorescence. Larvae for immunostaining
were selected from the general pool and not within a particular level
of PED-6 uptake. For statistical comparisons, chi-square analysis was
performed (http://www.graphpad.com).
Immunostaining and electron microscopy
Whole-mount cytokeratin immunostaining of wild-type and
morpholino-injected larvae were performed as previously described
(Matthews et al., 2004; Lorent et al., 2004). Brieﬂy, 10–15 larvae per
injection round were randomly selected, ﬁxed in 80% MeOH/20%
DMSO, peeled, stained with monoclonal antibody Ks18.04 (RDI
Division of Fitzgerald Industries) and then stained with appropriate
secondary antibody. For electron microscopy, larvae at 5 dpf were
ﬁxed, prepared, and examined as previously (Matthews et al., 2009).
Quantiﬁcation of duct stainings was performed largely similar to
previous (Matthews et al., 2004). Total ducts were counted and
terminal ductules were counted as previously. “Interconnecting
ducts” were deﬁned more strictly for the quantiﬁcations presented
here, as ducts were considered interconnecting only if both ends
clearly terminated in another duct. Duct length was calculated similar
to previous, using a Photoshop grid as the unit of length. Lengths are
presented with the caveat that they were quantiﬁed as two-
dimensional images of a three-dimensional structure. Duct angle
and width were calculated using ImageJ. Angles were determined by
measuring the most acute angle between a main duct and an
offshooting duct, and averaging all of the angles within a sample;
the angles reported are the means of the averages from each sample.
As with duct length, angles may not be the exact angle in a three-
dimensional network.Width is reported asmm, based on each sample
micrograph as 5 cm × 5 cm and as determined by ImageJ. Numbers
depicted represent means±S.E.M. of 6 samples per condition, with t-
tests.
PCNA and TUNEL stainings were performed similar to previous
(Matthews et al., 2005). Brieﬂy, for PCNA staining, 4 dpf control and
pk1aMO-injected larvae were stained withαPCNA and 2F11 followed
by the appropriate ﬂuorescent secondary antibodies, and livers were
examined by confocal microscopy. 2F11-positive cells were examined
for concomitant PCNA staining; even faint PCNA staining was counted
as positive. For hepatocytes, livers were counterstained with DAPI,
and non-2F11-positive cells were counted.While this will count some
endothelial cells, hepatocytes greatly outnumber endothelial cells,
and we did not count cells with elongated nuclei more typical of
endothelial cells. For TUNEL staining, larvae were raised in PTU and
then stained using Apoptag (Millipore), similar to previous. We used
0.1N HCl as a positive control, also similar to previous.
Quantitative real-time PCR
Template cDNA was synthesized from RNA obtained from 5 dpf
control and pk1a MO-injected whole larvae derived from three
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described (Matthews et al., 2004). Analysis was performed as
described previously (Matthews et al., 2004).
Results
Developmental expression of PCP genes in zebraﬁsh liver
We expected PCP genes to be expressed in the liver during the
formation of nascent bile ducts, which would support a role for PCP in
biliary development. Others have examined PCP gene expression at
earlier stages of zebraﬁsh development; in general, PCP expression is
diffuse at early stages and then becomes restricted to the developing
nervous system (Park and Moon, 2002; Veeman et al., 2003). We
examined PCP gene expression at 3 dpf, at which point the bile ducts
are beginning to form (Lorent et al., 2004; Matthews et al., 2004). PCP
gene expression at these later stages has not previously been
examined. As depicted in Fig. 1, our results demonstrated that several
PCP genes, including pk1a, dsh2, vangl2, dsh3, wnt11, wnt11r and
ankrd6 were expressed in the developing liver at 3dpf. Several other
PCP genes, however, such as pk2 (Fig. 1), celsr1, celsr2 and celsr3 (data
not shown) were not detectable in the liver at 3 dpf, although we did
detect celsr expression at earlier stages in the developing nervous
system (data not shown). The lack of celsr expression in the liver
suggests that other genes may occupy this role in the liver, or that PCP
functions without celsr in the liver. We did not observe expression of
these PCP genes in the developing pronephros (Fig. 1), consistent with
published expression patterns at earlier stages (http://www.zﬁn.org).
Our expression results support a potential role of PCP in hepatobiliary
development.
Knockdown of PCP genes leads to abnormal PED6 uptake and defects in
biliary development
To assay the function of PCP genes in zebraﬁsh biliary develop-
ment, we performed gene knockdown experiments using antisenseFig. 1. Expression of PCP genes in 3 dpf zebraﬁsh larvae. Whole-mount RNA in situ
hybridization of PCP genes prickle 1a (pk1a) (A), dishevelled 2 (dsh2) (B), van gogh-like
2 (vangl2) (C), dishevelled 3 (dsh3) (D),wnt11 (E), wnt11r (F), ankyrin-related domain
containing 6 (ankrd6) (G), and prickle 2 (pk2) (H). Note the liver staining (black
arrows) present for A–G, but not in H.morpholino oligonucleotides (MOs). Morpholinos were designed to
target the 5' translational start site or the splice acceptor site for exon
7 of the pk1a gene. Others have previously reported that knockdown
of pk1a or pk1b in zebraﬁsh leads to defects in gastrulation and
neuronal migration (Carreira-Barbosa et al., 2003; Rohrschneider et
al., 2007; Takeuchi et al., 2003; Veeman et al., 2003), but we used
lowerMO concentration to avoid effects on gastrulation that would be
lethal. We focused our studies on pk1a. Fig. S1 demonstrates
knockdown after injection at the one-cell stage or at 2 dpf.
The general morphology of the pk1a morphant larvae was
preserved, although liver size appeared somewhat reduced (Fig. 2).
Gallbladder ﬂuorescence following the ingestion of the quenched
ﬂuorescent lipid, PED6 (Farber et al., 2001), was reduced in pk1a
morpholino-injected larvae (Fig. 2). We classiﬁed gallbladder PED6
uptake as “normal” (Fig. 2C), “faint” (Fig. 2D), or “absent” (Fig. 2E),
and using this method determined that pk1aMO injection resulted in
a signiﬁcant decrease in biliary function (see Supplemental Fig. 2 for
breakdown of results, n=77 control, 269 morphants, pb0.0001).
Abnormal gallbladder uptake of PED6 is consistent with defects in
intrahepatic biliary development. Thus, these results suggest that PCP
defects may lead to defective intrahepatic biliary development.
Interestingly, we also observed an increase in left-sided gallbladders
in larvae injected with pk1aMOs (Fig. 2F and Fig. S2), suggesting that
pk1a knockdown may affect left-right digestive organ location. Left-
sided gallbladders were also of decreased intensity (Fig. 2F). We did
not observe gallbladder sidedness defects, although we did observe
intensity defects, after pk1a morpholino injection at 2 dpf (data not
shown), suggesting that the positional defects arise earlier than 2 dpf.
To determine whether pk1a knockdown leads to abnormal
intrahepatic biliary development, we performed cytokeratin immu-
nostaining of 5 dpf pk1a morphants. In zebraﬁsh larvae injected with
pk1a MO, intrahepatic bile ducts demonstrated abnormal anatomy
compared with control (Fig. 2G–I). As also depicted in the schematics
in Fig. 2J–L and Table 1, the number of ducts was signiﬁcantly reduced
in the morphant, and there were fewer terminal ductules and
interconnecting ducts (ducts that clearly connect one duct with
another). The defects observed in cytokeratin immunostaining were
also seen in larvae injected with pk1a morpholinos at 2 dpf (data not
shown). Control MOs included vehicle control, as well as standard and
random control MOs; results from all types of negative controls were
indistinguishable (Fig. 2 and data not shown). The cytokeratin
immunostaining results are thus consistent with the PED6 results
and demonstrate that knockdown of pk1a perturbs intrahepatic
biliary development in zebraﬁsh.
We performed similar knockdown experiments with MOs against
vangl2 and ankrd6. As depicted in Fig. 2K–L, knockdown of vangl2,
which encodes the vertebrate equivalent of the Prickle-binding
protein Strabismus, led to a similar pattern of abnormal intrahepatic
biliary development, as did knockdown of ankrd6, which encodes the
vertebrate equivalent of the Prickle antagonist Diego (see Fig. S1 for
documentation of knockdown of both vangl2 and ankrd6). Quantita-
tive analysis of duct number and characteristics noted in cytokeratin
immunostainings of pk1a, vangl2 and ankrd6 MO-injected larvae
support a similar but milder effect for both vangl2 and ankrd6
knockdown (Table 1). Gallbladder PED6 uptake in these morphants
also demonstrated abnormally placed left-sided gallbladders (data
not shown). These ﬁndings suggest that inhibition of the Prickle/
Strabismus aspect of PCP leads to developmental biliary defects in
zebraﬁsh, and may affect digestive organ localization as well.
Loss of pk1a leads to abnormal localization of digestive organs
As depicted in Fig. 2, there was an increase in the number of left-
sided gallbladders in larvae injected with pk1a MO. Others have
demonstrated that inhibition of PCP activity leads to the failure of the
forming gut to migrate to the midline, leading to bilateral expression
Fig. 2. Altered PED6 gallbladder uptake and bile duct defects in pk1a morphants. (A–B) Left lateral view of live 5 dpf control (A, cont) and pk1a morpholino-injected (B, pk1a MO)
larvae. Liver size (black outline) appears smaller in (B), but otherwise the larvae appear similar. (C–F) PED6 uptake in control (C) and three examples of pk1a morphants (D–F),
showing decreased uptake (D), no uptake (E), and abnormal left-sided placement of the gallbladder (F) in pk1amorphants. Note that the view of (C–E) is right lateral and that of (F)
is left lateral to show the gallbladder sidedness. (G–I) Confocal projections of whole-mount cytokeratin immunostainings of random control MO-injected (G) and pk1amorphant (H,
I) livers at 5 dpf demonstrate decreased number and complexity of intrahepatic bile ducts in the pk1amorphants. (J–L) Line schematics of ducts in (G–I) to clarify the duct staining
pattern. (M–O) Confocal projections of whole-mount cytokeratin immunostainings of livers from 5 dpf larvae injected with standard (std) control MO (M) and larvae injected with
MOs against vangl2 (N) or ankrd6 (O). Note that the pattern of the ducts in (N) and (O) is similar to the ducts in the pk1aMO-injected larva (H, I). Similar results were obtained with
either the AUG or splice blocking pk1a, vangl2, and ankrd6 MOs.
232 S. Cui et al. / Developmental Biology 351 (2011) 229–241of various endodermal organ markers at 2 dpf (Matsui et al., 2005). Of
note, we did not observe bilateral gallbladders by PED6 uptake in any
morphant ﬁsh. To determine whether pk1a knockdown led to
abnormal localization of other digestive organs, we performed in
situ hybridizations with digestive organ markers on pk1amorphants.
In normal 3 dpf zebraﬁsh larvae, the liver and intestine are on the left
side, while the pancreas, which contains one islet, and the gallbladder,
are on the right side (Wallace and Pack, 2003). As depicted in Fig. 3,
expression of the liver gene ceruloplasmin (cp) was abnormal in 3 dpf
pk1amorphants, with a signiﬁcant number of larvae showing the liver
extending from the left side over themidline, a bilateral liver, or a liver
on the right side. We observed similar defects in position of the
intestine as well as both the exocrine and endocrine pancreas(Supplemental Figs 3–5). Our results are consistent with the previous
results of Matsui et al., but further demonstrate that by later time
points, the early mislocalization of developing digestive organs may
result in abnormal localization of more mature forms of these organs.
More recent studies have demonstrated the importance of PCP in
establishing left-right asymmetry (Antic et al., 2010; Song et al.,
2010), but our results showing occasional “extended”marker staining
out from the midline seem more consistent with migration defects.
Forced expression of pk1a leads to abnormal biliary development
To ensure that the abnormal intrahepatic biliary development
noted in pk1a morphants is speciﬁc to pk1a MO injection and not a
Table 1
Quantiﬁcation of bile duct defects in pk1a, vangl2, and ankrd6morpholino-injected larvae. Total numbers of ducts, interconnecting ducts (IC), and terminal ductules are depicted in
control, pk1a, vangl2 and ankrd6MO-injected larvae. Also depicted are average duct length, width, and angles between branching ducts. Length is based on grids in Photoshop, while
width is measured as mm from a 5 cm × 5 cm image. Angles refer to the average angle at which ducts grow out from other ducts, measuring the most acute angle; there was
considerable variability within samples but the average angles were remarkably consistent. *pb0.05, **pb0.005, ***pb0.0005. Values without asterisks are not signiﬁcantly different
from control. n=6 per condition, ±S.D.
Condition No. of ducts No. of IC ducts No. of terminal ductules Duct length Duct width Duct angles
Control 50.2±5.7 16.8±5.0 84.7±17.4 1.64±0.22 0.413±0.053 80.2±3.7
pk1a MO 21.5±11.1*** 1.3±0.8*** 16.8±6.9*** 1.20±0.30* 0.401±0.056 71.0±4.2*
vangl2 MO 20.5±2.9*** 3.2±2.1*** 15.0±9.7*** 1.55±0.58 0.357±0.038 76.8±4.3
ankrd6 MO 24.2±10.3*** 5.2±5.0** 20.2±8.2*** 1.38±0.35 0.379±0.028 76.7±4.3
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pk1aMOwith pk1amRNA. As depicted in Fig. 4, co-injection ofMO and
mRNA led to normalization of both PED6 gallbladder intensity and
sidedness, suggesting that both effects are due to speciﬁc inhibition of
Pk1a activity in the pk1amorphants. Fig. 4A further suggests that pk1a
mRNA injection alone may have a modest effect on biliary develop-
ment, as gallbladder intensity is decreased in larvae injectedwith pk1a
mRNA. Interestingly, forced expression of pk1a mRNA did not appear
to affect gallbladder left-right sidedness, although injection of the
mRNA with the morpholino did appear to rescue that aspect of the
phenotype. Cytokeratin immunostaining of liver from 5 dpf larvae
injected with pk1amRNA demonstrated abnormal intrahepatic biliary
anatomy (Fig. 4D), suggesting that forced expression of pk1a perturbs
intrahepatic biliary development. Furthermore, co-injection of pk1a
morpholino andmRNA led to normalization of the phenotype (Fig. 4E).
These results demonstrate that the effect of pk1a knockdownon biliary
development is speciﬁc, and also suggest that forced expression of
pk1a leads to defects in biliary development. The differential effects ofFig. 3. Abnormal liver localization in pk1amorphants. Whole-mount in situ hybridization of c
location, including “right extended” (B), “bilateral” (C), and “right” (D). (E) Graph depicting
of abnormally localized livers (9% vs. 67%, pb0.0001 by chi-square test), while the difference
data for localization defects in other organs.pk1amRNA injection on gallbladder sidedness vs. intrahepatic biliary
defects suggest that these phenotypes may result from separate
mechanisms of Prickle action.
Cellular defects in pk1a morphants
Defects in intrahepatic biliary development may be caused by
global defects in the liver affecting both the developing hepatocytes
and bile duct cells, or by defects speciﬁcally affecting either the
developing hepatocytes or bile duct cells. The expression studies in
Fig. 1 suggested that pk1a is expressed throughout the liver, or
possibly only in the larger and more prevalent hepatocytes. To further
elucidate the developmental biliary defects in pk1a morphants, we
examined biliary cells in the morpholino-injected larvae using the
marker 2F11, which stains bile duct cells (Crosnier et al., 2005). Fig. 5
demonstrates that 2F11 staining showed fewer bile duct cells and less
extensive projections to neighboring cells, consistent with the
cytokeratin staining demonstrating fewer and less complex ducts.eruloplasmin (cp), a liver marker, in 3 dpf pk1amorphants demonstrates abnormal liver
the scoring of pk1amorphants demonstrates a signiﬁcant difference in the total number
in livers limited to the right side is not signiﬁcant (9% vs. 8%). Please see supplemental
Fig. 4. Effect of pk1a on biliary development. (A, B) Bar graphs depicting PED6 uptake in control (cont), pk1amorpholino-injected (pk1a MO), pk1amRNA-injected, and pk1aMO and
mRNA-injected larvae. In (A), the percentage of larvae with no gallbladder (GB) uptake, faint uptake, and normal uptake is depicted on the Y-axis. In (B), numbers of larvae with
abnormal left-sided GBs are depicted. Note that pk1amRNA injection leads to an increase in the number of faint gallbladders compared to control (pb0.0001), while mRNA injection
leads to a rescue of the MO phenotype (pb0.0001 compared to MO injection, NS compared to control). Forced expression of pk1a mRNA has no effect on GB sidedness, but does
rescue the morphant sidedness phenotype. (C–E) Confocal projections of whole-mount cytokeratin staining of livers from 5 dpf control (B, cont), pk1amRNA-injected (C) and pk1a
MO and mRNA injection (D). Note that mRNA injection alone leads to scattered short duct-like structures, while mRNA and MO co-injection leads to rescue of the MO phenotype.
234 S. Cui et al. / Developmental Biology 351 (2011) 229–241As depicted in Fig. 5 and Table 2, there were fewer bile duct cells in the
morphants, as determined by 2F11 and DAPI costaining; there were
fewer hepatocytes as well, but the proportion of bile duct cells is
decreased in the morphants, suggesting that the effect may be more
severe in bile ducts.
To determine whether the changes in biliary cell number were due
to increased cell death or decreased cell division, we examined pk1a
morphant larvae stainedwith TUNEL or PCNA. There was no apoptotic
cell death appreciated in pk1a morphant or control larvae (data not
shown), but Fig. 5 and Table 3 demonstrate that there was
signiﬁcantly less bile duct cell proliferation in 4 dpf pk1a morphant
larvae, while hepatocyte proliferation was similar to control. In
contrast to the results of 5 dpf larvae in Table 2, at 4 dpf there appear
to be similar numbers of hepatocytes, possibly because of slower
growth in the morphants that is manifested at 5 dpf. The decrease in
bile duct cell proliferation most likely leads to the decreased number
of bile duct cells observed in the morphants. The decreased number of
bile duct cells likely plays a role in the biliary developmental defects.To more closely examine the hepatocytes and bile duct cells in the
pk1a morphants, we examined tissue sections. There was no
appreciable difference in the appearance of liver sections in control
and pk1aMO-injected larvae by hematoxylin and eosin staining (data
not shown). Given the lack of a lobular structure and portal triads in
teleost larvae and adults (Hinton and Couch, 1998), differences may
be more difﬁcult to appreciate by this method, however. Thus, we
examined larvae by electron microscopy. As depicted in Fig. 5E–F,
lower magniﬁcation views demonstrated generally preserved mor-
phology, although there appeared to be an accumulation of vesicles in
hepatocytes near canaliculi, and bile within the ducts appeared
abnormal (Fig. 5F). Higher magniﬁcation views of bile duct cells
demonstrated abnormal-appearing Golgi and accumulation of intra-
cellular vesicles (Fig. 5G–H). The phenotypic distinction between
hepatocytes and bile duct cells evident in both controls and
morphants suggests that the defects after pk1a knockdown are
probably not related to defects in differentiation, as that would be
expected to lead to a more homogeneous population of cells in the
Fig. 5. Abnormal bile duct cells in pk1amorphant livers. (A–B) Single confocal optical slices of whole-mount 2F11 and PCNA immunostaining of livers from 5 dpf control (A, cont) and
pk1amorphant (B) larvae. 2F11 staining is in green, PCNA in red, and DAPI counterstain in blue. Hepatocytes are noted with small white dots, while biliary cells are noted with larger
dots. Solid dots represent cells that are PCNA positive, while the open dots are PCNA negative. Note that the biliary cells in control are all PCNA positive, while there are PCNA
negative biliary cells in the pk1amorphant. (C-F) Electron micrographs from livers from control (C, E, cont) and pk1amorpholino-injected (D, F, pk1aMO) larvae. (C–D) Low power
views (scale bar 2 μm) demonstrate overall similarity in appearance, but canaliculi (white arrowheads) appear to have accumulated material within in the morphants (D), and there
is an accumulation of vesicles (black arrows) in the hepatocytes in (D). (E–F) Higher power views (scale bar 500 nm) demonstrate dilated Golgi (white arrow) in the bile duct cell in
the morphant sample (F), as well as an accumulation of intracellular vesicles (F, white arrowhead). The white outlines circumscribe the bile duct cells in C–F.
Table 2
Numbers of biliary cells in pk1amorphants. Confocal projections of 2F11 immunostain-
ing of livers from control and pk1aMO-injected 5 dpf larvae were assayed for total cell
number (by DAPI staining) and bile duct cell (BDC) number (by 2F11 and DAPI). The
total cell number is lower in the morphants, but the number of bile duct cells is lower
than would be expected. Means represent average of 5 samples, ±S.D.
Total cells Bile duct cells %BDC
Control 562.4±37.9 58.0±7.0 10.3±1.0
pk1a MO 371.2±115.0 30.6±9.2 8.3±1.0
pb0.03 pb0.001 pb0.03
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defects in intracellular trafﬁcking, although these vesicles could be
secondary to poor bile ﬂow and resulting impaired transport to the
canalicular membrane. These results suggest that pk1a knockdown
affects both hepatocytes and bile duct cells, although the greater effect
on bile duct cell number noted above suggests that the effects on bile
duct cells may be more severe.
Inhibition of downstream PCP targets also leads to biliary defects
PCP familymembers have been shown to exert effects via RhoA and
Rho kinase (Strutt et al., 1997), and c-Jun N-terminal kinase (JNK)
(Yamanaka et al., 2002). Therefore,we examinedwhether inhibition of
Table 3
Decreased bile duct cell proliferation in pk1a morphants. Bile duct cells (BDCs) and
hepatocytes from livers from 4 dpf control and pk1a MO-injected larvae were assayed
for cell proliferation, using PCNA to label proliferating cells and 2F11 to label BDCs.
There is a signiﬁcant reduction in proliferating BDCs in the morphants, as an absolute
number and as a percentage of the total number of BDCs. There is no difference in the
number of proliferating hepatocytes. Means represent an average of 5 samples, ±S.D.
Similar results were obtained with either pk1a MO.
No. of BDCs No. of BDCs with PCNA % Proliferating
Control 28.8±2.8 26.2±2.3 91.1±3.7
pk1a MO 24.2±5.6 18.4±3.8 76.6±7.0
p=N.S. pb0.005 pb0.005
No. of hepatocytes No. of hepatocytes
with PCNA
% Proliferating
Control 151.8±29.8 133.3±21.7 88.3±3.9
pk1a MO 150.8±29.9 130.7±32.4 86.0±4.6
p=N.S. p=N.S. p=N.S.
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and Table 4, intrahepatic biliary anatomy was abnormal at 5 dpf in
larvae treated with the Rho kinase inhibitors fasudil (Tamura et al.,
2005) and H-1152 (RKI) (Ikenoya et al., 2002), and after treatment
with the JNK inhibitor dicoumeral (Cross et al., 1999). There is
phenotypic similarity between intrahepatic bile ducts in pk1a
morphants and larvae treated with the Rho kinase inhibitors, with
fewer and shorter ducts (Figs. 6 and S6, Table 4). Ducts from larvae
treatedwith the JNK inhibitor appearmore severely affected, however,
suggesting that JNK inhibition may overlap with other pathways in
addition to PCP. These results do support a role for PCP in biliary
development, though, as inhibition of Rho kinase or JNK negatively
affects intrahepatic biliary development, consistent with involvement
of pathways downstream of PCP in zebraﬁsh biliary development.
Rho kinase and JNK exert effects on the cytoskeleton, affecting both
the actin and microtubule cytoskeletons (Ciani et al., 2004; Takeuchi et
al., 2003). We examined biliary development after treatment with the
actin inhibitor cytochalasin D or the microtubule inhibitor colchicine to
determine whether inhibition of cytoskeletal components could affect
biliary development. As depicted in Fig. 6 (as well as Table 4 and Fig. S6),
treatmentwith either cytochalasinDor colchicine led to abnormal biliary
development, similar to Rho kinase inhibition and to knockdownof pk1a,
butmilder than JNK inhibition. To determinewhether PCP inhibition and
the colchicine or cytochalasin D effects were epistatic, we injected pk1a
MOsand cytochalasinDor colchicine at doses that alone resulted in no or
only mild effects. As demonstrated in Fig. 6, while there was no effect of
these treatments alone on gallbladder PED6 uptake in the larvae, when
combined there was a signiﬁcant reduction in gallbladder intensity.
Cytokeratin immunoﬂuorescence was abnormal only in the livers from
larvae treatedwith both the pk1aMOand colchicine or cytochalasin D in
low doses (Fig. 6), as expected from the results with PED6. These results
suggest that the biliary defects noted from PCP gene knockdownmay be
mediated via effects on the cytoskeleton, as would be expected given
previous results on downstream targets of PCP.
pk1a and hnf6 knockdown are synergistic
The appearance of the developmental defects in pk1a morphants
and in larvae injected with pk1a mRNA was similar to the pattern
observed with knockdown and forced expression of hnf6, and similarFig. 6. Inhibition of Rho kinase, JNK, and cytoskeletal architecture negatively affects biliary
from a 5 dpf control larvae (A), compared to similar stainings from larvae treated with th
dicoumeral (D), the actin inhibitor cytochalasin D (E), and the microtubule and cytoskeleton
PCP leads to a phenotype similar to the pk1a morphant phenotype. (G) Bar graph depicti
morpholino, low dose cytochalasin D, or the combination. Note that alone, the low dose MO
and signiﬁcant (pb0.0005, chi-square). (H) Bar graph depicting PED6 treatment of control la
the combination. Note that only in the combination is there a statistically signiﬁcant effect
cytokeratin immunostaining of livers from 5 dpf control larvae (I) and larvae injected with
(colch, L), and low dose pk1a MO with low dose cytochalasin D (M) or low dose colchicineto vhnf1 mutants (Matthews et al., 2004). Thus, we examined
expression of vhnf1, a downstream target of hnf6, in pk1amorphants.
vhnf1 expression was decreased in pk1amorphants, as determined by
quantitative PCR normalizing to hprt (Fig. 7) and liver-speciﬁc cp
(data not shown). In situ hybridization also demonstrated a decrease
in liver expression of vhnf1 (Fig. 7), while expression of cp appeared
relatively constant, regardless of the placement of the liver (Fig. S7).
These results are consistent with pk1a acting upstream of vhnf1.
Similar to the experiments described above, we injected pk1a and
hnf6 MOs at lower doses singly and in combination to determine
whether inhibition of these genes worked synergistically, suggesting
that the two gene products work in the same pathway. As depicted in
Fig. 7 and quantiﬁed in Table 5, only knockdown of both genes led to
decreased PED6 gallbladder uptake and abnormal cytokeratin
immunostaining, suggesting that pk1a and hnf6 are operating in the
same pathway. This overlap likely at least includes effects on vhnf1 but
may also involve additional effects. Interestingly, injection of hnf6MO
did not seem to affect gallbladder sidedness (data not shown),
suggesting that the effect of hnf6 is on intrahepatic biliary morpho-
genesis only. Consistent with this, injection of vhnf1 mRNA into pk1a
morphants led to rescue of gallbladder PED6 intensity but not
sidedness, and improved the appearance of pk1a MO-injected
intrahepatic bile ducts (Fig. 7 and Table 5). Injection of vhnf1 mRNA
led to rescue of the pk1amorphant biliary phenotype after injection of
pk1a MO at the 1-cell stage (Fig. 7 and Table 5) or at 2 dpf (data not
shown). Interestingly, vhnf1 injection did not rescue the decrease in
duct angle, suggesting that directional duct outgrowth may not be
dependent on vhnf1, although there was considerable variability in
duct angle within samples. These results suggest that pk1a, hnf6 and
vhnf1 function in the same genetic pathway in zebraﬁsh intrahepatic
biliary development, and that forced expression of vhnf1 rescues PCP
defects caused by pk1a knockdown.
Discussion
One in 3000 infants develops hepatobiliary disease leading to poor
bile ﬂow within the ﬁrst few months of life. Among the less common
causes of infantile hepatobiliary diseases are disorders in which
patients also develop kidney cysts, although some of these disorders
may also manifest later in life as well. Recently, abnormalities in PCP
signaling were found to be associated with kidney cysts. Here, we
present data from zebraﬁsh that support an importance of PCP
signaling in hepatobiliary development. Multiple PCP members were
expressed in the liver during biliary development. Morpholino
antisense-mediated knockdown of pk1a and other PCP genes demon-
strated impaired bile duct formation, and we also observed defects in
left–right location of multiple digestive organs. We have presented
additional evidence supporting a role for PCP in biliary development,
as inhibition of known downstream targets of PCP such as Rho kinase,
JNK, and cytoskeletal components also led to biliary defects. Finally,we
demonstrated that these effects are in the same pathway as hnf6 and
vhnf1 – transcription factors important in biliary development.
Importance of PCP in biliary development
Examination of PCP in vertebrates has demonstrated a role for PCP in
early developmental phenomena such as gastrulation (Takeuchi et al.,development. (A–F) Whole-mount projections of cytokeratin immunostaining of liver
e Rho kinase inhibitors fasudil (B) and H-1152 (RKI, C), as well as the JNK inhibitor
inhibitor colchicine (F). Note that inhibition of any of the above downstream targets of
ng PED6 treatment of control larvae compared to larvae treated with low dose pk1a
or cytochalasin have no to minimal effect, but that in combination, the effect is sizable
rvae compared to larvae treated with low dose pk1amorpholino, low dose colchicine, or
on PED6 gallbladder uptake (pb0.0001, chi-square test). (I–N) Confocal projections of
low dose (l.d.) pk1a MO (J), low dose cytochalasin D (cyto D, K), low dose colchicine
(N). Note that (J–L) appear similar to control (I), but that (M, N) are abnormal.
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Table 4
Quantiﬁcation of bile duct defects in larvae treated with various chemical inhibitors. Total numbers of ducts, interconnecting ducts (IC), and terminal ductules are depicted in control,
fasudil-, RKI-, dicoumeral-, colchicine-, and cytochalasin D-treated larvae. Also depicted are average duct length, width, and angles between branching ducts. Length is based on grids
in Photoshop, while width is based on mm from a 5 cm × 5 cm image. *pb0.05, **pb0.005, ***pb0.0005. Values without asterisks are not signiﬁcantly different from control. n=6
per condition, ±S.D.
Condition No. of ducts No. of IC ducts No. of terminal ductules Duct length Duct width Duct angles
Control 50.2±5.7 16.8±5.0 84.7±17.4 1.64±0.22 0.413±0.053 80.2±3.7
Fasudil 27.2±10.8** 3.5±3.2*** 22.3±5.7*** 1.11±0.27** 0.363±0.038 73.0±4.2*
RKI 28.7±11.4** 5.8±4.2** 31.2±8.4*** 1.59±0.56 0.411±0.048 78.7±7.0
Dicoumeral 22.7±4.6*** 0.2±0.4*** 11.3±7.3*** 1.14±0.35* 0.531±0.114* 78.6±6.8
Colchicine 32.0±14.8* 3.2±2.9*** 15.5±11.1*** 1.13±0.35* 0.411±0.076 72.0±4.4*
Cytochalasin 29.7±12.7** 1.8±1.5*** 24.0±24.7** 1.20±0.35* 0.424±0.064 77.0±8.6
238 S. Cui et al. / Developmental Biology 351 (2011) 229–2412003; Veeman et al., 2003; Wallingford et al., 2000) and neurulation
(Wang et al., 2006), as well as in later phenomena such as neurite
outgrowth (Okuda et al., 2007) establishment of the neuromuscular
junction (Jing et al., 2009), cochlear development (Wang et al., 2005),
and the renal collecting system (Fischer et al., 2006; Saburi et al., 2008).
Inmanyof these examples, there is directionality in cell growth; e.g., the
renal collecting system elongates in one direction. PCP proteins may beFig. 7. hnf6 and vhnf1 act downstream of PCP in zebraﬁsh biliary development. (A) Qua
demonstrating a 40% decrease in vhnf1 expression in the morphants. (B, C) In situ hybridiza
vhnf1 in pronephric ducts in both conditions (white arrowheads), but no expression in the
that knockdown of pk1a and hnf6 is synergistic with respect to an effect on gallbladder PED
larvae injected with the combination of low dose pk1a and hnf6MOs, showing a pattern of i
Similar graph of PED6 gallbladder intensity for rescue of pk1a knockdown phenotype by vhn
Confocal projection of cytokeratin immunostaining of livers from 5 dpf larvae injected withacting as cues dictating the direction inwhich cellular proliferation and/
or movement occur during growth and development.
A role for PCP in mediating cell proliferation and movement in
intrahepatic biliary differentiation seems plausible. In zebraﬁsh,
intrahepatic ducts appear by 60 hpf, and over the next several days
the ducts lengthen, although new bile duct cells continue to appear
(Lorent et al., 2010; Lorent et al., 2004). Branching and interconnectingntitative real-time PCR of vhnf1 expression in control and pk1a MO-injected larvae
tions of 3 dpf control (B, cont) and pk1a MO-injected larvae (C) showing expression of
morphant liver (white arrow) or intestine (i). (D) Epistasis experiment demonstrating
6 intensity. (E) Confocal projection of cytokeratin immunostaining of livers from 5 dpf
ntrahepatic bile ducts similar to that seen after knockdown of pk1a, seen elsewhere. (F)
f1mRNA injection demonstrating improvement in gallbladder intensity (p=0.03). (G)
pk1aMOwith vhnf1mRNA, demonstrating a pattern similar to control, seen elsewhere.
Table 5
Quantiﬁcation of bile duct defects in larvae treated with pk1a MO-injection and hnf6 MO or vhnf1 RNA injection. Total numbers of ducts, interconnecting ducts (IC), and terminal
ductules are depicted in control larvae, and larvae injected with pk1aMO, low dose (ld) pk1aMO and low dose hnf6MO, and pk1aMO plus vhnf1mRNA. Also depicted are average
duct length, width, and angles between branching ducts. Length is based on grids in Photoshop, while width is based on mm from a 5 cm × 5 cm image. *pb0.05, **pb0.005,
***pb0.0005. Values without asterisks are not signiﬁcantly different from control. n=6 per condition, ±S.D.
Condition No. of ducts No. of IC ducts No. of terminal ductules Duct length Duct width Duct angles
Control 50.2±5.7 16.8±5.0 84.7±17.4 1.64±0.22 0.413±0.053 80.2±3.7
pk1a MO 21.5±11.1*** 1.3±0.8*** 16.8±6.9*** 1.20±0.30* 0.401±0.056 71.0±6.9*
ld pk1a MO+ld hnf6 MO 18.0±9.8*** 0.7±0.8*** 26.2±21.0*** 1.34±0.53 0.374±0.010 73.6±3.4*
pk1a MO+vhnf1 mRNA 37.7±11.0* 14.0±4.6 94.2±28.9 1.98±0.27* 0.408±0.071 73.3±4.5*
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2004). Intrahepatic bile ducts in the pk1a MO-injected, Rho kinase or
cytoskeletal inhibitor-treated larvae have fewer and shorter ducts
than control larvae, and resemble the intrahepatic ductal pattern of a 3
dpf larva. There are fewer bile duct cells in pk1amorphants,most likely
from a decrease in cell proliferation. Decreased cell proliferation has
been observed previously in other models after inhibition of PCP
activity, notably in angiogenesis (Cirone et al., 2008), a process that
appears similar to intrahepatic biliary development in zebraﬁsh. Thus,
our results in zebraﬁsh are consistent with a model in which PCP
family members are important in bile duct cell proliferation, affecting
intrahepatic duct proliferation and lengthening, similar to the role of
PCP family members in other systems. In mammals, intrahepatic
biliary development proceeds out towards the periphery of the liver
(Roskams and Desmet, 2008); PCP proteins could be involved in duct
lengthening in mammals as well.
We also provide evidence that PCP inhibition leads to a decrease in
the expression of vhnf1, a homeodomain transcription factor down-
stream of hnf6 that is important in biliary development in mammals
(Clotmanet al., 2002; Cofﬁnier et al., 2002) and zebraﬁsh (Matthews et
al., 2004). Zebraﬁsh vhnf1 mutants not only demonstrate biliary
defects (Matthews et al., 2004), but kidney cysts as well (Sun and
Hopkins, 2001). More recent evidence demonstrates that vhnf1 is also
critical for early stages of liver speciﬁcation in both mammals and
zebraﬁsh (Lokmane et al., 2008). Our results suggest that the effect of
PCP on vhnf1may bemore important in the later stages, inwhich vhnf1
plays a role in biliary development, as pk1a knockdowndoes not result
in complete lack of liver formation. Moreover, vhnf1 mRNA injection
rescued biliary defects in both early and late MO-mediated inhibition
of pk1a, supporting a role for pk1a in the later effects of vhnf1 on biliary
development.Whether vhnf1 expression is affected by Pk1a directly or
indirectly is as yet unclear, but the possibility of a direct mediation of
Hnf6 or vhnf1 gene expression by PCP is intriguing.
The combination of effects of PCP on biliary development,
involving effects on cell proliferation, intracellular trafﬁcking, and
hnf6/vhnf1 activity suggests a possible role for TGFβ signaling. PCP
defects could result in impaired trafﬁcking of TGFβ or its receptor,
both of which have been shown to be important for TGFβ signaling (Le
Roy andWrana, 2005; Roth-Eichhorn et al., 1998). TGFβ activity leads
to increased liver cell proliferation (Fausto et al., 1995), is activated in
differentiation of hepatoblasts into biliary cells (Ader et al., 2006), and
is involved in a complex regulatory pathway with Hnf6 in mediating
biliary development (Clotman et al., 2005). Pk1a has been shown to
interact with several other proteins, including transcription factors
(Shimojo and Hersh, 2003), and thus the effect on hnf6 or vhnf1 could
also be mediated through an interaction with a transcription factor
that binds both Pk1a and the hnf6 or vhnf1 promoter. The mechanism
of PCP inhibition on biliary developmentmay be due to one ormore of
the above effects.Importance of PCP in digestive organ localization
We demonstrated an increase in the number of abnormally sided
gallbladders in larvae injectedwith pk1aMOs. Furthermore,we showedthat knockdown of pk1a led to abnormal distribution of endodermal
tissue markers with respect to the left–right body axis, suggesting that
inhibition of PCP activity is associated with formation of intestine, liver
and pancreas on either or both sides of this axis. Our digestive marker
stainingswere not always discretely localized to one side or the other, as
they occasionally demonstrated extension from themidline to the left or
right. These results are consistent with previous results demonstrating
bilateral localization of normally asymmetrically localized endodermal
tissues at earlier stages (Matsui et al., 2005). We cannot exclude a role
for early left–right cues, as recently shown for PCP genes Vang1 and Pk2
in mice and Xenopus (Antic et al., 2010; Song et al., 2010), but the
presence of the “extended” digestive markers seems more consistent
with a migration defect.
Matsui et al. demonstrated that inhibition of PCP activity leads to
persistence of endodermal cells lateral to the developing gut tube,
suggesting that PCP activity is necessary for successful migration of
these cells to the midline. In zebraﬁsh, endodermally derived organs
such as the liver and pancreas may develop from tissue surrounding
the nascent gut tube (Wallace and Pack, 2003), or from the developing
gut tube itself (Field et al., 2003a; Field et al., 2003b). Our data are
compatible with both models, as inhibition of PCP activity may lead to
ectopic development of pancreas and liver because of a failure of the
developing gut tube to become restricted to the midline. Inhibition of
PCP activity may also inhibit lateral movement of cells in developing
endodermal organs to the correct side, resulting in the persistent
expression of markers extending from the midline. Regardless, our
results corroborate those of Matsui et al. proposing a role for PCP
activity in directional cell migration during endodermal development.
The effect of PCP inhibition on digestive development thus appears to
lead to abnormally formed tissues thatmay also end upwith abnormal
left–right placement, which is most strongly supported by our results
showing abnormal biliary development and left-sided gallbladder.
The constellation of left–right digestive organ localization defects,
biliary defects, and kidney cysts is found in various combinations in
several clinical conditions, including both rare disorders and more
common conditions such as autosomal recessive polycystic kidney
disease and syndromic biliary atresia (Maclean and Dunwoodie, 2004).
Examinationof genetic etiologies of these conditionshas focusedonearly
left–right asymmetry genes and cilia genes, but recent work implicates
PCP in at least some of these conditions (Bacallao andMcNeill, 2009; Kim
et al., 2010). Although adirect connectionbetweenPCP core proteins and
ciliogenesis in mammals is not evident, several studies have shown a
functional interaction between PCP processes and cilia (Ferrante et al.,
2009; Gray et al., 2009; Heydeck et al., 2009; Maisonneuve et al., 2009;
Mitchell et al., 2009; Ross et al., 2005), suggesting that defects in these
pathways could lead to similar phenotypes. Thus, it would seem likely
that defects in PCP would lead to developmental biliary defects and
associated clinical ﬁndings such as left–right anomalies, both in
vertebrate models and possibly in patients as well.PCP as one of several pathways involved in biliary development
Wehave presented evidence that inhibition of PCP negatively affects
biliary development in zebraﬁsh. This is a previously undescribed role
Fig. 8. Schematic pathway interactions in biliary development. Depicted is a schematic
of various pathways known to be important in biliary development and the relationship
between each pathway. Positive regulation is noted by red arrows, negative by green.
Most relationships depicted are based on previous studies; our studies presented here
on PCP are included. Possible or unclear relationships are noted with dashed lines. NTG,
Notch target genes.
240 S. Cui et al. / Developmental Biology 351 (2011) 229–241for PCP. There does appear to be an interaction between PCP and Hnf6
and/or vhnf1, previously known to be important in biliary development.
Our data do not address where this interaction may be, other than both
PCP and Hnf6 mediating biliary effects through vhnf1. There may be
additional functional interactions between PCP and other known
pathways in biliary development, such as Jagged/Notch, TGFβ, and
cilia proteins. As stated above, there are well-established functional
interactions between PCP and cilia proteins, and both of these pathways
can affect TGFβ signaling (Guo andWang, 2009), which is also involved
with both Jagged/Notch (Guo and Wang, 2009) and HNF6 (Clotman et
al., 2005) signaling. Thus, PCP appears to participate in a complex
regulatory network governing biliary development (Fig. 8).
Supplementarymaterials related to this article can be found online
at doi:10.1016/j.ydbio.2010.12.041.
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